NCT02265952 Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH) Status COMPLETED Phase PHASE2
NCT02260986 Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT02260687 Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Status COMPLETED Phase N/A
NCT02210780 Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT02204683 Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration Status COMPLETED Phase PHASE1
NCT02134028 Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) Status COMPLETED Phase PHASE3
NCT02127801 Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants Status COMPLETED Phase PHASE1
NCT02121210 To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT02121080 Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02107898 Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN) Status COMPLETED Phase PHASE3
NCT02107872 Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 Status COMPLETED Phase PHASE1
NCT02097524 Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT02092532 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Status UNKNOWN Phase PHASE4
NCT02085005 Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT02061865 Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD Status COMPLETED Phase PHASE1
NCT02057250 To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02045030 Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02040220 Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) Status COMPLETED Phase N/A